Autolus Therapeutics plc ADR (NASDAQ: AUTL) is -40.37% lower on its value in year-to-date trading and has touched a low of $2.01 and a high of $7.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AUTL stock was last observed hovering at around $3.75 in the last trading session, with the day’s gains setting it 0.09%.
Currently trading at $3.84, the stock is -7.41% and -4.89% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.82 million and changing 2.40% at the moment leaves the stock -21.63% off its SMA200. AUTL registered 30.61% gain for a year compared to 6-month loss of -43.78%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -9.65% gain in the last 1 month and extending the period to 3 months gives it a -12.53%, and is 4.35% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.85% over the week and 6.53% over the month.
Autolus Therapeutics plc ADR (AUTL) has around 463 employees, a market worth around $1.02B and $10.50M in sales. Profit margin for the company is -2229.04%. Distance from 52-week low is 91.04% and -48.46% from its 52-week high. The company has generated returns on investments over the last 12 months (-28.80%).
with sales reaching $150k over the same period.The EPS is expected to grow by 30.12% this year, but quarterly earnings will post 796.90% year-over-year. Quarterly sales are estimated to shrink -63.10% in year-over-year returns.
Autolus Therapeutics plc ADR (AUTL) Top Institutional Holders
The shares outstanding are 266.05M, and float is at 236.60M with Short Float at 5.25%.
The top institutional shareholder in the company is SYNCONA PORTFOLIO LTD with over 21.35 million shares valued at $$136.19 million. The investor’s holdings represent 9.6083 of the AUTL Shares outstanding. As of 2024-03-31, the second largest holder is BLACKSTONE INC. with 20.49 million shares valued at $$130.7 million to account for 9.2207 of the shares outstanding. The other top investors are DEEP TRACK CAPITAL, LP which holds 15.27 million shares representing 6.8741 and valued at over $$97.44 million, while AVORO CAPITAL ADVISORS LLC holds 5.5568 of the shares totaling 12.35 million with a market value of $$78.77 million.
